ArticleFrontiers in oncology2022

Metabolic Risks Are Increasing in Non-B Non-C Early-Stage Hepatocellular Carcinoma: A 10-Year Follow-Up Study.

Yen-Po Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.